Home > News > Pharmaceutical industry looks to commercial metathesis 13th February 2007
February 13th, 2007
Pharmaceutical industry looks to commercial metathesis 13th February 2007
Commercially available metathesis catalysts could provide drugs manufacturers with new opportunities.
Olefin metathesis is one of the most versatile ways of making carbon-carbon bonds and the process has been exploited by petrochemical, polymer, and specialty chemical industries to process simple hydrocarbons for almost 50 years.
China is expected to drive the global nanotechnology and catalysts market this year, a new report claims. Research firm RNCOS predicts that nanoscience will gain huge investment over the next twenty years, bringing about radical changes in the pharmaceutical industry.
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017
New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017
Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017
Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017
Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017
Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017
Video captures bubble-blowing battery in action: Researchers propose how bubbles form, could lead to smaller lithium-air batteries April 26th, 2017